MRTX9768: a synthetic lethal-based inhibitor designed to bind the PRMT5•MTA complex and target M...

Discovery of MTA-Cooperative PRMT5 Inhibitors for the Treatment of MTAP-Deleted Cancer.Подробнее

discovery of MRTX1719 for cancer indications - drug annotationsПодробнее

Synthetic lethality | Synthetic Lethal Interactions | BRCA Mutation & PARP Inhibition |Подробнее

Drug Combinations for Synthetic Lethal Interactions | Protocol PreviewПодробнее

Exploiting Synthetic Lethality To Improve Cancer TherapyПодробнее

What is synthetic lethality?Подробнее

Synthetic Lethality in Cancer Therapeutics - OICR MondaysПодробнее

CRISPR screens to identify novel DNA repair defects synthetic lethal therapiesПодробнее

MiSL: a method for mining synthetic lethal partners of... - Subarna Sinha - RECOMB/RSG 2015Подробнее

Cancer Dependency Mapping to Guide Drug DiscoveryПодробнее

💊 Unlocking Synthetic Lethality: Targeting PARP Inhibition in BRCA1 and BRCA2 Mutant Cancers 🛑Подробнее

Batterer Intervention Program MSR 2.0Подробнее

What is synthetic lethality?Подробнее

Mechanisms of PARP Inhibition: A Mode of Targeted Cancer TreatmentПодробнее

Gould: PRMT5 Inhibitors for Hematologic CancerПодробнее

Mechanisms of DNA Damage and RepairПодробнее

MIS 23 Sneak Peek - Scatter Removal ToolПодробнее

Lyn Jones - Dana-Farber Targeted Degradation Webinar SeriesПодробнее